Category — Healthcare

Siemens Launches Mobile Diagnostic Device in India

Siemens Healthineers,  part of the Siemens Group, launched a device that embeds mobile technology with diagnostics in India.

“We have signed an exclusive agreement with Jana Care for Aina, a blood monitoring system. It will be the world’s first smart phone-based diagnostic system, which will enable detection and management of chronic diseases such as diabetes and cardiac conditions,” said Anuj Dhingra of Siemens Healthineer. Jana Care is a Bangalore-based diabetes care company.

Aina Device

Meaning ‘mirror’ in Hindi, Aina offers a broad range of tests such as HbA1c glucose, hemoglobin and a lipid profile on a single platform covering immunoassay, enzymatic or chemical affinity. Aina is available in two configurations–a smart phone-based device and tablet-based portable lab system. After connecting with the smart phone, it acts like a diagnostic testing device enabling real-time, lab-quality results within minutes, added Dhingra. A “Habits” app,  comes integrated with the Aina device,  serves virtual diabetes coach that helps patients reach their diet and exercise goals through personalized daily checklists which includes tips, tasks, lessons and quizzes.

This integrated diagnostics and disease management platform is approved for use in Europe, India, Singapore and Malaysia.

February 16, 2018   No Comments

Roche Diagnostics Expands to India’s Smaller Cities

Roche Diagnostics is aiming at 15 percent share of India’s in-vitro diagnostics market in the next two years  said Shravan Subramanyam, managing director for Roche Diagnostics for  India & Neighboring Markets.

“We are also seeing consolidation of our customers, that is labs, and we would like to access tier II and tier III cities and rural markets through them and get a larger piece of the diagnostics market,” Subramanyam added.

Roche Diagnostic Devices

Currently the company sells devices and equipment to labs and hospitals and is mainly in the business-to-business space. For the next five years, the company will focus on women’s health, non communicable diseases:  diabetes, cardio vascular diseases, cancer and wellness segments. “But as India still has a very high burden of infectious diseases, we will continue to be in the space of infectious diseases,” Subramanyam affirmed. 

February 16, 2018   No Comments

Philips Launches AI Supported Imaging Solutions in India

Netherlands-based Philips has introduced three Artificial Intelligence-driven imaging solutions in India:

-> Access CT 32 Slice offers flexibility, better image quality, and diagnostic accuracy.

-> Ingenia Prodiva 1.5T MRI is built on dStream digital broadband technology and can accelerate patient throughput.

-> DuraDiagnost F30 Digital X-ray helps to simplify clinical decision-making and aims to improve outcomes for patients.

Philips Ingenia MRI Imaging Device

Philips Ingenia MRI Imaging Device

“The new offerings in MRI, CT and Digital X-ray are developed to help radiologists diagnose faster, more accurately, with the added benefit of lower ownership costs and better patient experience,” Rohit Sathe, president Philips Healthcare, India, said.

February 16, 2018   No Comments

Abbott India’s Sales and Profits Rose Last Quarter

Net profit of Abbott India rose 34.86% to over $17 million in the quarter ended December 2017  compared $14 million during the same quarter of the previous year.  Sales rose 18.08% to over $136 million  in the same quarter  compared to  $116 million during the previous quarter that ended December 2016.

 Medication

 

 

February 16, 2018   No Comments

India Simplifies Licensing for Medical Device Manufacturing

Per India’s Medical Device Rules, 2017 that came into effect in January this year, new licenses awarded for manufacturing and import of medical devices will not need periodical renewal and will remain valid until they are either suspended, cancelled, or surrendered. The licensee will need to pay a retention fee once every five years for the license to remain valid.

India’s federal regulator, the Central Drugs Standard Control Organization has launched Sugam, an online portal, to facilitate granting licenses for manufacturing, import, clinical investigation, sale and distribution of medical as well as in vitro diagnostics devices.

Authorities will inspect manufacturing sites  annually ensure compliance to the terms and conditions stipulated in the licenses. Manufacturers are required to follow a quality management system for manufacturing medical devices.

Blood pressure monitor

February 15, 2018   No Comments